Select Publications
Journal articles
1989, 'Does hyperketonemia affect protein or glucose kinetics in postabsorptive or traumatized man?', Journal of Surgical Research, 47, pp. 313 - 318, http://dx.doi.org/10.1016/0022-4804(89)90141-8
,1988, 'Glucose kinetics in protein depletion - Effect of glucose infusion in the fasted rat', Journal of Nutrition, 118, pp. 1240 - 1244, http://dx.doi.org/10.1093/jn/118.10.1240
,1988, 'Glucose kinetics in protein depletion-Effects of infusion of lipid emulsions containing medium chain (MCT) and long chain triglycerides (LCT)', Clinical Nutrition, 7, pp. 21 - 23, http://dx.doi.org/10.1016/0261-5614(88)90006-4
,1988, 'Total Parental Nutrition Using Conventional and Medium Chain Triglycerides: Effect on Liver Function Tests, Complement, and Nitrogen Balance', Journal of Parenteral and Enteral Nutrition, 12, pp. 15 - 19, http://dx.doi.org/10.1177/014860718801200115
,1987, 'Lipogenesis in liver, heart, white and brown adipose tissue of protein-depleted rats', Journal of Nutrition Growth and Cancer, 4, pp. 209 - 214
,1986, 'The metabolic consequences of infusing emulsions containing medium chain triglycerides for parenteral nutrition: A comparative study with conventional lipid', Annals of the Royal College of Surgeons of England, 68, pp. 119 - 121
,1986, 'Metabolic studies of a lipid emulsion containing medium-chain triglyceride in perioperative and total parenteral nutrition infusions', World Journal of Surgery, 10, pp. 38 - 46, http://dx.doi.org/10.1007/BF01656088
,1985, 'A new intravenous emulsion containing medium-chain triglyceride: Studies of its metabolic effects in the perioperative period compared with a conventional long-chain triglyceride emulsion', Journal of Parenteral and Enteral Nutrition, 9, pp. 720 - 724, http://dx.doi.org/10.1177/0148607185009006720
,1984, 'What do patients eat in hospital?', Human Nutrition: Applied Nutrition, 38, pp. 294 - 297
,1984, 'The effect of pre‐operative glucose loading on postoperative nitrogen metabolism', British Journal of Surgery, 71, pp. 635 - 637, http://dx.doi.org/10.1002/bjs.1800710828
,1984, 'WHAT DO PATIENTS EAT IN HOSPITAL', HUMAN NUTRITION-APPLIED NUTRITION, 38A, pp. 294 - 297, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1984TK28700007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Papers
2020, 'IS SPIO/USPIO-ENHANCED MRI SENSITIVE AND SPECIFIC FOR AXILLARY STAGING IN PATIENTS WITH BREAST CANCER? A SYSTEMATIC REVIEW AND META-ANALYSIS', in BREAST, CHURCHILL LIVINGSTONE, pp. 160 - 160, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000519815500046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Synergistic effect of targeting EGFR and metabolism in sarcoma cell lines', Brisbane, Australia, presented at 2015 Annual Sarcoma Conference, Brisbane, Australia, 17 October 2015 - 18 October 2015
,2012, 'Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors', in Cancer Research, American Association for Cancer Research, United States, presented at 103rd Annual Meeting of AACR, Chicago, IL, PA, 31 March 2012 - 04 April 2012
,2010, 'Abstract 1655: Mechanism of the synergistic antiproliferative effect of gefitinib and interferon-alpha in sarcoma cell lines', in Cancer Research, American Association for Cancer Research (AACR), pp. 1655 - 1655, http://dx.doi.org/10.1158/1538-7445.am10-1655
,2008, 'IGF1R targeted therapy in human osteosarcoma cell lines', in Bone, Elsevier Science Inc, New York, NY, USA, pp. S111 - S111, presented at Bone
,2006, 'Potential application of EGFR targeted therapies in different types of sarcomas', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, Philadelphia, PA, USA, presented at 97th Annual Meeting of AACR, Washington DC, USA, 01 April 2006 - 05 April 2006
,2004, 'A modified Eilber protocol provides maximum local control and minimummajor morbidity in soft tissue sarcoma', in Annals of Surgical Oncology, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. S80 - S80, presented at Society of Surgical Oncology 57th Annual Cancer Symposium, New York, 18 March 2004 - 21 March 2004
,2003, 'Expression of IGF mitogenic signals in adult soft tissue sarcomas', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. 106 - 106, presented at Royal Australasian College of Surgeons Annual Scientific meeting (RACS 2003), Brisbane, Qld, 05 May 2003 - 09 May 2003
,2001, 'Wound healing in nude mice - a mechanical, histological and immunohistochemical study', in ANZ Journal of Surgery, Blackwell Publishing, pp. A130
,2000, 'Improved local control with neoadjuvant chemoradiotherapy in patients with extremity soft tissue sarcoma', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. A80, presented at Australian and New Zealand Journal of Surgery 2000
,2000, 'Plasminogen activation system in prognosis of colorectal cancer', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. A56, presented at Australian and New Zealand Journal of Surgery 2000
,2000, 'Prophylactic mastectomy in Australia: Results of a nation wide survey', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. A34, presented at Australian and New Zealand Journal of Surgery 2000
,2000, 'Who needs axillaey dissection?', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. A30, presented at Australian and New Zealand Journal of Surgery 2000
,1999, 'Genomic Alteration on Chromosome 17q21-23 and Liver Metastasis of Sporadic Colorectal Cancer', in 11th Lorne Cancer Conference, Lorne, Victoria, pp. 500, presented at 11th Lorne Cancer Conference, Lorne, Victoria, 04 February 1999
,1999, 'Urokinase-type plasminogen activator receptor in metastatic colorectal cancer.', in 11th Lorne Cancer Conference, Lorne, Victoria, pp. 230, presented at 11th Lorne Cancer Conference, Lorne, Victoria, 04 February 1999
,1999, 'Urokinase-type plasminogen activator receptor in invasion and metastasis of human colorectal cancer', in American Society of Clinical Oncology, pp. 243a
,1999, 'Wound healing and growth factor expression in the presence of T-lymphocyte deficiency', in Austrlian and New Zealand Journal of Surgery, Blackwell Publishing Ltd, pp. A81 - A82
,1998, 'Effects of Altered States of Immune Function on wound healing and Wound Growth Factor Expression.', in Tow Prize DayPOWH/PHH, Sydney, presented at Tow Prize DayPOWH/PHH, Sydney, 30 October 1998
,1998, 'Protein markers in metastasis of colorectal cancer', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, pp. 50
,1998, 'Reducation of invasive/metastatic potential in human colon cancer cells transfected with anti-sense urokinase-type plasminogen activator receptor', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, pp. 416
,1997, 'Expression of KAI1 in benign and malignant human colonic tissues and liver metastasis', in Australian Gastroenterology Conference, Brisbane, Qld, presented at Australian Gastroenterology Conference, Brisbane, Qld, 23 October 1997 - 31 October 1997
,1996, 'Expression of c-erbB-2 mRNA and c-neu in metastatic colorectal cancers.', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. 199 - 199, presented at ANZ Journal of Surgery: Supp 1, Geelong Hospital, Victoria, 22 August 1996 - 24 August 1996
,Conference Proceedings (Editor of)
Yang JL; Kuang J; Crowe PJ, (eds.), 2008, 'Bone', Elsevier Science Inc, New York, NY, USA, presented at Bone
Conference Posters
2017, 'In vitro and in vivo effect of targeting CDK4/6 and mTOR singly or together in sarcoma cell lines', Adelaide, Australia, presented at 2017 Annual Sarcoma Conference, Adelaide, Australia, 13 October 2017 - 14 October 2017
,2017, 'Anti-prolifeative effect of targeting CDK4/6 and mTOR alone or in combination in sarcoma cell lines', Florence, Italy, presented at EACR-AACR-SIC: The Challenges of optimising immuno and targeted therapies: from cancer biology to the clinic, Florence, Italy, 24 June 2017 - 27 June 2017
,2015, 'Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma', Lorne, Victoria, Australia, Vol. 7, pp. 21496 - 21509, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015, http://dx.doi.org/10.18632/oncotarget.7452
,2015, 'Targeting the PI3K/PTEN/AKT/mTOR pathway in sarcoma cell lines', Lorne, Victoria, Australia, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015
,2014, 'Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines', San Diego, CA, PA, presented at The 105th Annual Meeting of the American Association for Cancer Research 2014, San Diego, CA, PA, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-172
,2013, 'Mechanisms of gefitinib alone and in combination therapy in soft tissue sarcoma cell lines', Boston, MA, US, presented at Molecular Targets and Cancer Therapeutics 2013, Boston, MA, US, 19 October 2013 - 23 October 2013
,2013, 'STAT3 inhibitor S3I-201 suppresses human osteosarcoma cell growth', Lorne, Victoria, Australia, presented at 25th Lorne Cancer Conference 2013, Lorne, Victoria, Australia, 14 February 2013 - 16 February 2013
,2012, 'Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors', presented at The 103rd Annual Meeting of AACR 2012, 31 March 2012 - 04 April 2012
,2012, 'STAT3-targeted therapy on human soft tissue sarcomas', Lorne, Victoria, Australia, presented at 24th Lorne Cancer Conference 2012, Lorne, Victoria, Australia, 09 February 2012 - 11 February 2012
,Conference Presentations
2014, 'Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-1723
,2009, 'Investigation of IGF-IR pathways in an orthotopic mouse model of human osteosarcoma with spontaneous pulmonary metastasis.', presented at IX International meeting on Cancer Induced Bone Disease., Arlington, VA USA, 28 October 2009 - 31 October 2009
,Conference Abstracts
2021, 'Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 47 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Synergistic effect of targeting both CDK4/6 and mTORin sarcoma cell lines', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-3907
,2016, 'Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, GERMANY, Munich, Vol. 69, pp. S37 - S38, presented at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, GERMANY, Munich, 29 November 2016 - 02 December 2016, http://dx.doi.org/10.1016/S0959-8049(16)32693-4
,2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, AUSTRIA, Vienna, http://dx.doi.org/10.1016/S0959-8049(16)31921-9
,2012, 'The role of human papillomaviruses in oesophageal squamous cell carcinoma: a review of the evidence', in INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, ELSEVIER SCI LTD, Vol. 16, pp. E351 - E352, http://dx.doi.org/10.1016/j.ijid.2012.05.431
,